The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AbbVie Inc. | Common | 00287Y109 | 9 | 156 | SH | SOLE | 156 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 20,000 | 715,299 | SH | SOLE | 715,299 | 0 | 0 | ||
Accelerate Diagnostics, Inc. | Common | 00430H102 | 3,803 | 264,625 | SH | SOLE | 264,625 | 0 | 0 | ||
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 2,414 | 296,934 | SH | SOLE | 296,934 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | Note 2.00% 8/15/19 | 00767EAB8 | 6,606 | 13,000,000 | PRN | SOLE | 13,000,000 | 0 | 0 | ||
Affimed NV | Common | N01045108 | 1,100 | 294,213 | SH | SOLE | 294,213 | 0 | 0 | ||
Agilent Technologies, Inc. | Common | 00846U101 | 28,447 | 713,850 | SH | SOLE | 713,850 | 0 | 0 | ||
Akorn, Inc. | Common | 009728106 | 5,770 | 245,235 | SH | SOLE | 245,235 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 88,656 | 636,805 | SH | SOLE | 636,805 | 0 | 0 | ||
Alkermes plc | Shares | G01767105 | 19,897 | 581,944 | SH | SOLE | 581,944 | 0 | 0 | ||
Allergan plc | Shares | G0177J108 | 109,781 | 409,586 | SH | SOLE | 409,586 | 0 | 0 | ||
Allergan plc | Preferred Convertible | G0177J116 | 4,596 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
Alliqua BioMedical, Inc. | Common | 019621200 | 1,353 | 1,650,000 | SH | SOLE | 1,650,000 | 0 | 0 | ||
Allscripts Healthcare Solutions, Inc. | Common | 01988P108 | 2,293 | 173,600 | SH | SOLE | 173,600 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 8,631 | 137,495 | SH | SOLE | 137,495 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 48,223 | 321,640 | SH | SOLE | 321,640 | 0 | 0 | ||
Amicus Therapeutics, Inc. | Common | 03152W109 | 2,180 | 258,000 | SH | SOLE | 258,000 | 0 | 0 | ||
Anacor Pharmaceuticals, Inc. | Common | 032420101 | 5,882 | 110,038 | SH | SOLE | 110,038 | 0 | 0 | ||
ARCA biopharma, Inc. | Common | 00211Y407 | 2,783 | 811,227 | SH | SOLE | 811,227 | 0 | 0 | ||
Ardelyx, Inc. | Common | 039697107 | 10,795 | 1,389,370 | SH | SOLE | 1,389,370 | 0 | 0 | ||
AstraZeneca PLC | Sponsored ADR | 046353108 | 10,019 | 355,800 | SH | SOLE | 355,800 | 0 | 0 | ||
Auris Medical Holding AG | Common | H03579101 | 3,037 | 834,263 | SH | SOLE | 834,263 | 0 | 0 | ||
Baxter International Inc. | Common | 071813109 | 13,129 | 319,600 | SH | SOLE | 319,600 | 0 | 0 | ||
BeiGene Ltd | Sponsored ADR | 07725L102 | 3,421 | 116,707 | SH | SOLE | 116,707 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 561 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
Biogen Inc. | Common | 09062X103 | 117,283 | 450,533 | SH | SOLE | 450,533 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 49,170 | 596,145 | SH | SOLE | 596,145 | 0 | 0 | ||
bluebird bio, Inc. | Common | 09609G100 | 2,097 | 49,345 | SH | SOLE | 49,345 | 0 | 0 | ||
Bristol-Myers Squibb Co. | Common | 110122108 | 12,942 | 202,600 | SH | SOLE | 202,600 | 0 | 0 | ||
Care Capital Properties, Inc. | Common | 141624106 | 2,263 | 84,316 | SH | SOLE | 84,316 | 0 | 0 | ||
Celator Pharmaceuticals, Inc. | Common | 15089R102 | 2,603 | 236,000 | SH | SOLE | 236,000 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 174,881 | 1,747,234 | SH | SOLE | 1,747,234 | 0 | 0 | ||
Celldex Therapeutics, Inc. | Common | 15117B103 | 400 | 105,800 | SH | SOLE | 105,800 | 0 | 0 | ||
Cellectis S.A. | Sponsored ADS | 15117K103 | 8,532 | 310,250 | SH | SOLE | 310,250 | 0 | 0 | ||
Centene Corporation | Common | 15135B101 | 7,388 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
Cepheid, Inc. | Common | 15670R107 | 11,129 | 333,590 | SH | SOLE | 333,590 | 0 | 0 | ||
Cepheid, Inc. | Note 1.25% 2/1/21 | 15670RAC1 | 8,906 | 10,000,000 | PRN | SOLE | 10,000,000 | 0 | 0 | ||
Chimerix, Inc. | Common | 16934W106 | 1,578 | 308,892 | SH | SOLE | 308,892 | 0 | 0 | ||
Cidara Therapeutics, Inc. | Common | 171757107 | 921 | 72,500 | SH | SOLE | 72,500 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 5,636 | 304,472 | SH | SOLE | 304,472 | 0 | 0 | ||
Corsicanto Ltd | Note 3.50% 1/15/32 | 220480AB3 | 11,714 | 14,700,000 | PRN | SOLE | 14,700,000 | 0 | 0 | ||
Cynapsus Therapeutics, Inc. | Common | 23257Y859 | 2,147 | 180,407 | SH | SOLE | 180,407 | 0 | 0 | ||
CytomX Therapeutics, Inc. | Common | 23284F105 | 4,232 | 328,059 | SH | SOLE | 328,059 | 0 | 0 | ||
DBV Technologies S.A. | Sponsored ADR | 23306J101 | 2,135 | 65,600 | SH | SOLE | 65,600 | 0 | 0 | ||
Depomed, Inc. | Common | 249908104 | 2,786 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Dynavax Technologies Corporation | Common | 268158201 | 4,636 | 240,950 | SH | SOLE | 240,950 | 0 | 0 | ||
Eli Lilly & Co | Common | 532457108 | 30,040 | 417,167 | SH | SOLE | 417,167 | 0 | 0 | ||
Endo International plc | Shares | G30401106 | 8,061 | 286,348 | SH | SOLE | 286,348 | 0 | 0 | ||
Endologix Inc. | Common | 29266S106 | 4,606 | 551,000 | SH | SOLE | 551,000 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 4,848 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Esperion Therapeutics, Inc. | Common | 29664W105 | 1,738 | 102,800 | SH | SOLE | 102,800 | 0 | 0 | ||
Exelixis, Inc. | Common | 30161Q104 | 5,622 | 1,405,420 | SH | SOLE | 1,405,420 | 0 | 0 | ||
Flamel Technologies SA | Sponsored ADR | 338488109 | 6,892 | 624,288 | SH | SOLE | 624,288 | 0 | 0 | ||
Flex Pharma, Inc. | Common | 33938A105 | 2,332 | 212,600 | SH | SOLE | 212,600 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd. | Shares | M46135105 | 6,299 | 966,065 | SH | SOLE | 966,065 | 0 | 0 | ||
Forward Pharma A/S | Sponsored ADR | 34986J105 | 2,321 | 136,547 | SH | SOLE | 136,547 | 0 | 0 | ||
Galapagos NV | Sponsored ADR | 36315X101 | 836 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
GenMark Diagnostics, Inc. | Common | 372309104 | 492 | 93,349 | SH | SOLE | 93,349 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 214,147 | 2,331,231 | SH | SOLE | 2,331,231 | 0 | 0 | ||
GlaxoSmithKline plc | Sponsored ADR | 37733W105 | 11,557 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
Grifols SA | Sponsored ADR | 398438408 | 2,568 | 166,000 | SH | SOLE | 166,000 | 0 | 0 | ||
Halozyme Therapeutics, Inc. | Common | 40637H109 | 1,894 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
HCA Holdings, Inc. | Common | 40412C101 | 26,147 | 334,998 | SH | SOLE | 334,998 | 0 | 0 | ||
Healthcare Realty Trust, Inc. | Common | 421946104 | 5,783 | 187,224 | SH | SOLE | 187,224 | 0 | 0 | ||
Healthcare Trust of America, Inc. | Common | 42225P501 | 5,238 | 178,033 | SH | SOLE | 178,033 | 0 | 0 | ||
Heron Therapeutics, Inc. | Common | 427746102 | 4,159 | 219,000 | SH | SOLE | 219,000 | 0 | 0 | ||
Horizon Pharma plc | Shares | G4617B105 | 12,426 | 749,900 | SH | SOLE | 749,900 | 0 | 0 | ||
Humana, Inc. | Common | 444859102 | 23,655 | 129,300 | SH | SOLE | 129,300 | 0 | 0 | ||
ICON plc | Shares | G4705A100 | 8,629 | 114,900 | SH | SOLE | 114,900 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 10,366 | 132,352 | SH | SOLE | 132,352 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 56,554 | 348,864 | SH | SOLE | 348,864 | 0 | 0 | ||
Immunomedics, Inc. | Note 4.75% 2/15/20 | 452907AK4 | 2,810 | 4,000,000 | PRN | SOLE | 4,000,000 | 0 | 0 | ||
Impax Laboratories, Inc. | Common | 45256B101 | 3,981 | 124,335 | SH | SOLE | 124,335 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 69,315 | 956,461 | SH | SOLE | 956,461 | 0 | 0 | ||
Inotek Pharmaceuticals Corporation | Common | 45780V102 | 3,607 | 487,392 | SH | SOLE | 487,392 | 0 | 0 | ||
Insmed Incorporated | Common | 457669307 | 2,263 | 178,600 | SH | SOLE | 178,600 | 0 | 0 | ||
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 5,221 | 187,800 | SH | SOLE | 187,800 | 0 | 0 | ||
iShares Nasdaq Biotechnology ETF | ETF | 464287556 | 15,041 | 57,670 | SH | SOLE | 57,670 | 0 | 0 | ||
Jazz Pharmaceuticals plc | Shares | G50871105 | 23,380 | 179,091 | SH | SOLE | 179,091 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 40,585 | 375,088 | SH | SOLE | 375,088 | 0 | 0 | ||
Juno Therapeutics, Inc. | Common | 48205A109 | 6,932 | 182,000 | SH | SOLE | 182,000 | 0 | 0 | ||
Karyopharm Therapeutics, Inc. | Common | 48576U106 | 4,463 | 500,324 | SH | SOLE | 500,324 | 0 | 0 | ||
Kite Pharma, Inc. | Common | 49803L109 | 1,882 | 41,000 | SH | SOLE | 41,000 | 0 | 0 | ||
Lexicon Pharmaceuticals, Inc. | Common | 528872302 | 2,362 | 197,641 | SH | SOLE | 197,641 | 0 | 0 | ||
LTC Properties Inc. | Common | 502175102 | 10,705 | 236,618 | SH | SOLE | 236,618 | 0 | 0 | ||
Mallinckrodt plc | Shares | G5785G107 | 13,721 | 223,900 | SH | SOLE | 223,900 | 0 | 0 | ||
McKesson Corporation | Common | 58155Q103 | 13,030 | 82,862 | SH | SOLE | 82,862 | 0 | 0 | ||
Medical Properties Trust, Inc. | Common | 58463J304 | 20,301 | 1,564,060 | SH | SOLE | 1,564,060 | 0 | 0 | ||
Medivation, Inc. | Common | 58501N101 | 30,682 | 667,300 | SH | SOLE | 667,300 | 0 | 0 | ||
Medtronic plc | Shares | G5960L103 | 41,783 | 557,104 | SH | SOLE | 557,104 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 36,037 | 681,097 | SH | SOLE | 681,097 | 0 | 0 | ||
Merrimack Pharmaceuticals, Inc. | Note 4.50% 7/15/20 | 590328AA8 | 2,205 | 1,485,000 | PRN | SOLE | 1,485,000 | 0 | 0 | ||
Merrimack Pharmaceuticals, Inc. | Common | 590328100 | 4,770 | 569,894 | SH | SOLE | 569,894 | 0 | 0 | ||
Molina Healthcare, Inc. | Common | 60855R100 | 22,436 | 347,901 | SH | SOLE | 347,901 | 0 | 0 | ||
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 1,420 | 153,700 | SH | SOLE | 153,700 | 0 | 0 | ||
Mylan NV | Shares Euro | N59465109 | 28,642 | 617,952 | SH | SOLE | 617,952 | 0 | 0 | ||
Natera, Inc. | Common | 632307104 | 8,400 | 882,358 | SH | SOLE | 882,358 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 12,318 | 311,460 | SH | SOLE | 311,460 | 0 | 0 | ||
Nevro Corp. | Common | 64157F103 | 2,802 | 49,800 | SH | SOLE | 49,800 | 0 | 0 | ||
Novartis AG | Sponsored ADR | 66987V109 | 6,715 | 92,700 | SH | SOLE | 92,700 | 0 | 0 | ||
Novavax, Inc. | Common | 670002104 | 1,847 | 358,000 | SH | SOLE | 358,000 | 0 | 0 | ||
Novo Nordisk A/S | ADR | 670100205 | 15,964 | 294,600 | SH | SOLE | 294,600 | 0 | 0 | ||
Omega Healthcare Investors Inc. | Common | 681936100 | 14,583 | 413,116 | SH | SOLE | 413,116 | 0 | 0 | ||
Paratek Pharmaceuticals, Inc. | Common | 699374302 | 11,568 | 762,581 | SH | SOLE | 762,581 | 0 | 0 | ||
Perrigo Company plc | Shares | G97822103 | 4,772 | 37,300 | SH | SOLE | 37,300 | 0 | 0 | ||
Pfizer, Inc. | Common | 717081103 | 53,708 | 1,812,011 | SH | SOLE | 1,812,011 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 22,868 | 1,230,772 | SH | SOLE | 1,230,772 | 0 | 0 | ||
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 7,312 | 3,848,191 | SH | SOLE | 3,848,191 | 0 | 0 | ||
Puma Biotechnology, Inc. | Common | 74587V107 | 7,642 | 260,200 | SH | SOLE | 260,200 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 55,604 | 154,266 | SH | SOLE | 154,266 | 0 | 0 | ||
Retrophin, Inc. | Common | 761299106 | 4,507 | 329,949 | SH | SOLE | 329,949 | 0 | 0 | ||
Revance Therapeutics, Inc. | Common | 761330109 | 786 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
Sabra Health Care REIT Inc. | Common | 78573L106 | 9,165 | 456,190 | SH | SOLE | 456,190 | 0 | 0 | ||
Sage Therapeutics, Inc. | Common | 78667J108 | 4,706 | 146,800 | SH | SOLE | 146,800 | 0 | 0 | ||
Sagent Pharmaceuticals, Inc. | Common | 786692103 | 3,489 | 286,650 | SH | SOLE | 286,650 | 0 | 0 | ||
Sanofi | Sponsored ADR | 80105N105 | 12,249 | 305,000 | SH | SOLE | 305,000 | 0 | 0 | ||
Senior Housing Properties Trust | Shares | 81721M109 | 11,995 | 670,504 | SH | SOLE | 670,504 | 0 | 0 | ||
Shire plc | Sponsored ADR | 82481R106 | 34,674 | 201,713 | SH | SOLE | 201,713 | 0 | 0 | ||
SPDR S&P Biotech ETF | S&P Biotech | 78464A870 | 15,188 | 294,000 | SH | SOLE | 294,000 | 0 | 0 | ||
St. Jude Medical, Inc. | Common | 790849103 | 14,070 | 255,810 | SH | SOLE | 255,810 | 0 | 0 | ||
Stryker Corporation | Common | 863667101 | 13,298 | 123,940 | SH | SOLE | 123,940 | 0 | 0 | ||
Supernus Pharmaceuticals, Inc. | Note 7.50% 5/1/19 | 868459AB4 | 6,026 | 2,000,000 | PRN | SOLE | 2,000,000 | 0 | 0 | ||
Tenet Healthcare Corporation | Common | 88033G407 | 4,759 | 164,500 | SH | SOLE | 164,500 | 0 | 0 | ||
Tetraphase Pharmaceuticals Inc. | Common | 88165N105 | 890 | 192,322 | SH | SOLE | 192,322 | 0 | 0 | ||
Teva Pharmaceutical Industries Ltd. | ADR | 881624209 | 35,956 | 671,958 | SH | SOLE | 671,958 | 0 | 0 | ||
The Medicines Company | Common | 584688105 | 17,932 | 564,438 | SH | SOLE | 564,438 | 0 | 0 | ||
The RMR Group Inc., Class A | Common | 74967R106 | 186 | 7,441 | SH | SOLE | 7,441 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 12,233 | 86,395 | SH | SOLE | 86,395 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 5,597 | 88,400 | SH | SOLE | 88,400 | 0 | 0 | ||
UniQure NV | Shares | N90064101 | 2,863 | 241,021 | SH | SOLE | 241,021 | 0 | 0 | ||
United Therapeutics Corporation | Common | 91307C102 | 10,374 | 93,100 | SH | SOLE | 93,100 | 0 | 0 | ||
UnitedHealth Group, Inc. | Common | 91324P102 | 52,733 | 409,100 | SH | SOLE | 409,100 | 0 | 0 | ||
Universal Health Services, Inc. | Common | 913903100 | 16,797 | 134,680 | SH | SOLE | 134,680 | 0 | 0 | ||
Valeant Pharmaceuticals International, Inc. | Common | 91911K102 | 4,155 | 158,000 | SH | SOLE | 158,000 | 0 | 0 | ||
Ventas, Inc. | Common | 92276F100 | 23,249 | 369,266 | SH | SOLE | 369,266 | 0 | 0 | ||
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 82,153 | 1,033,503 | SH | SOLE | 1,033,503 | 0 | 0 | ||
Welltower, Inc. | Preferred | 95040Q203 | 12,420 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Xencor, Inc. | Common | 98401F105 | 268 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Zafgen, Inc. | Common | 98885E103 | 89 | 13,307 | SH | SOLE | 13,307 | 0 | 0 | ||
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 10,908 | 102,300 | SH | SOLE | 102,300 | 0 | 0 |